SCHEMBL19909203

SCHEMBL19909203

Cc1cc(-c2cc(-n3c4ccccc4c4ccc(-c5ccc(C#N)cc5)cc43)c(C#N)c(-n3c4ccccc4c4ccc(-c5ccc(C#N)cc5)cc43)c2)cc(C)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 1/20 0.38
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
ATM Q13315 1/20 0.37
PTGER4 P35408 2/20 0.37
ABCG2 Q9UNQ0 1/20 0.34
EGLN2 Q96KS0 1/20 0.34
ALDH1A1 P00352 3/20 0.33
KDM4E B2RXH2 2/20 0.33
HPGD P15428 2/20 0.33
HSD11B1 P28845 1/20 0.33
PIK3CD O00329 1/20 0.33
PIK3CA P42336 1/20 0.33
HRH4 Q9H3N8 1/20 0.33
METAP2 P50579 1/20 0.33
HSD17B10 Q99714 1/20 0.33
AR P10275 1/20 0.33
PDE10A Q9Y233 1/20 0.33
ELANE P08246 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19909199 0.94 CHEK1 (0.41) CHEK1KMT2AEGLN2ALDH1A1HSD11B1
SCHEMBL19909204 0.93 METAP2 (0.33) KMT2AMEN1ATMPTGER4ALDH1A1
SCHEMBL19913302 0.93 KDM4E (0.40) ALDH1A1KDM4EHPGDMETAP2HSD17B10
SCHEMBL19913313 0.92 PDE9A (0.39) ALDH1A1KDM4EHPGDMETAP2HSD17B10
SCHEMBL19919736 0.92 PTGER4 (0.36) KMT2AMEN1ATMPTGER4ABCG2
SCHEMBL22563382 0.91 ABCG2 (0.40) CHEK1KMT2AMEN1ATMPTGER4
SCHEMBL19919668 0.91 ADORA2A (0.38) KMT2AMEN1ABCG2ALDH1A1HSD17B10
SCHEMBL19913312 0.90 KDM5B (0.39) ALDH1A1KDM4EHPGDMETAP2HSD17B10
SCHEMBL19908985 0.90 ALDH1A1 (0.42) KMT2AALDH1A1KDM4EHPGDMETAP2
SCHEMBL21279085 0.89 CHEK1 (0.35) CHEK1KMT2AMEN1ATMPTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
US-10665792-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2020-05-26 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
EP-3287451-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 CHEK1 3673/4885KMT2A 4771/4885MEN1 3205/4885
US-10665792-B2 Organic molecules for use in optoelectronic devices OR10J3, CFD, AOX1 CHEK1 2506/4885KMT2A 3507/4885MEN1 2554/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 CHEK1 3673/4885KMT2A 4771/4885MEN1 3205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.